Related by context. Frequent words. (Click for all words.) 69 thrombotic events 65 lipid lowering drugs 65 cardiovascular morbidity 63 myocardial infarction stroke 63 thromboembolic events 63 Lp PLA2 62 KRAS mutations 62 atherothrombosis 62 myocardial infarction MI 61 acute coronary 61 de ath 61 coronary revascularization 61 serum uric acid 61 antithrombotic 61 atherosclerotic disease 60 colorectal adenomas 60 perinatal mortality 60 multivariate analyzes 60 lipid lowering therapy 60 cardiovascular mortality 60 hsCRP 60 thromboembolism 59 fatal myocardial infarction 59 tumor lysis syndrome 59 systemic embolism 59 elevated CRP 59 QT prolongation 59 cardiovascular hospitalization 59 statin therapy 59 Recurrence Score 59 Combination therapy 59 intracerebral hemorrhage 59 irbesartan 59 hepatotoxicity 58 fasting glucose levels 58 HbA1C 58 subgroup analyzes 58 antihypertensive drugs 58 cerebrovascular events 58 serum concentrations 58 vascular inflammation 58 serum calcium 58 secondary hyperparathyroidism 58 fondaparinux 58 BRCA mutations 58 heavily pretreated 58 liver transplant recipients 58 metabolic abnormalities 58 cardiac toxicity 58 ischemic cardiomyopathy 58 HDL C 58 serum cholesterol 58 virologic failure 57 Epidemiological studies 57 cardio protective 57 calcium supplementation 57 antihypertensive medications 57 mycophenolate mofetil 57 folate intake 57 anti fibrotic 57 neuropsychiatric symptoms 57 T2DM 57 nonadherence 57 modifiable risk 57 T2D 57 cerebral infarction 57 genetic polymorphisms 57 HbA 1c 57 endometrial cancers 57 BRCA2 mutations 57 colorectal cancer CRC 57 rosuvastatin 57 myocardial infarction 57 mRNA expression 57 renal dysfunction 57 Ischemic 57 myocardial infarctions 57 morbidity mortality 57 angiotensin converting enzyme inhibitors 57 antiplatelet agents 57 familial hypercholesterolemia 56 density lipoprotein cholesterol 56 androgen deprivation 56 antihypertensive agents 56 cyclooxygenase 2 56 candesartan 56 lipid profiles 56 composite endpoint 56 antiplatelet therapy 56 annualized relapse 56 neoadjuvant 56 cardiac dysfunction 56 univariate 56 glitazones 56 fibrinolysis 56 comorbid conditions 56 PROMACTA 56 platelet activation 56 hyperglycaemia 56 N Engl J 56 breast carcinoma